PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498737
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498737
Radiotheranostics Market, By Radioisotope, By Approach, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Radiotheranostics Market size was valued at USD 2,115.2 Million in 2023, expanding at a CAGR of 14.20% from 2024 to 2032.
Radiotheranostics is a new area of medicine that combines the use of radiopharmaceuticals for both therapeutic and diagnostic purposes. It includes the simultaneous diagnosis and treatment of illnesses with the use of radiotracers, which are molecules tagged with radioactive isotopes. It involves using single-photon emission computed tomography (SPECT) or positron emission tomography (PET) imaging to see particular molecular targets or biomarkers within the body. Giving comprehensive details regarding the location and severity of the disease facilitates accurate and customized diagnosis. The therapeutic component entails applying the same radiotracer or a comparable substance to give targeted radiation therapy directly to the site of sickness.
Radiotheranostics Market- Market Dynamics
Growing Cancer Prevalence to Propel Market Growth
It is anticipated that the market for radiotheranostics will continue to develop as cancer incidence rises. Uncontrollably growing body cells that spread to other parts of the body are known as cancerous conditions. When it comes to cancer, radionuclide probes that are paired for both diagnostic and therapeutic purposes are used to detect and treat specific (usually cancerous) cells in a targeted and selective manner. Each probe is tailored to the patient's underlying condition, improving treatment outcomes and efficiency. This is how radionuclide medicine goes beyond personalized medicine. For instance, over 18 million new instances of cancer were discovered in 2020, according to Cancer Research UK, a UK-based cancer research organization. Furthermore, it is projected that by 2040, there will be 28 million additional instances of cancer worldwide, a 54.9% rise from 2020 and that this increase would disproportionately affect men (60.6% increase) compared to women (48.8% increase). Consequently, the market for radiotheranostics is driven by the rising incidence of cancer.
Radiotheranostics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.20% over the forecast period (2024-2032)
Based on approach segmentation, the targeted therapeutic category was predicted to show maximum market share in the year 2023
Based on application segmentation, the oncology category was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Radiotheranostics Market- Segmentation Analysis:
The Global Radiotheranostics Market is segmented on the basis of Radioisotope, Approach, Application, and Region.
The market is divided into two categories based on radioisotope: Iodine-131, lodine-123, Gallium-68, Lutetium-177, 18F with Y-90, and Other radioisotopes. The lutetium-177 category dominates the market, which is fueled by the market's growing LU-177 product usage and availability. Furthermore, Lu-177 has a longer half-life than other therapeutic isotopes, allowing for a longer course of treatment and possibly better patient outcomes. For instance, Springer states that L-177 has a 6.7-day physical half-life. Recent product approvals and fresh releases have also accelerated the segment's growth. Moreover, Novartis was granted European Commission approval in December 2022 to market Pluvicto, a targeted radioligand therapy, for the treatment of prostate cancer.
The market is divided into the following categories based on application: Oncology (Thyroid cancer, Neuroendocrine tumors, Hepatocellular carcinoma, Prostate cancer, Other oncology applications) and Non-oncology (Neurological disorders, Arthritis, Other non-oncology applications). The oncology category dominates the market and is likely to maintain its dominance during the forecast period. This high percentage can be explained by the fact that cancer radiotheranostics items are widely available in space. Furthermore, new product approvals, impending product launches, and the changing need for developing cutting-edge imaging tools and treatment solutions are all projected to fuel industry expansion. Pluvicto, LUTATHERA, AZEDRA, and other cancer-related theranostics are a few examples. The effectiveness of cancer radiotheranostic drugs has increased due to healthcare professionals' preference for nuclear medicine. Furthermore, it is anticipated that rising research expenditures in innovative nuclear medicine for cancer disorders will support business growth.
Radiotheranostics Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for radiotheranostics. The market for radiotheranostics in North America is being pushed by the demand for therapeutic radiopharmaceuticals, a growing trend towards precision medicine, and the increased usage of efficient imaging technologies. Moreover, the sector in the area is being driven by a multiplicity of industrial actors and their different strategic endeavours. For example, in March 2023, Ratio Therapeutics Inc. announced that it has licenced a Merck targeted medication used in PET imaging.
In addition, the radiotheranostics market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The high cancer prevalence in the area and growing nuclear medicine investments are the main factors propelling the growth of the regional market. For instance, in March 2021, Global Medical Solutions, Ltd. and BWXT Medical Ltd. announced that they will be working together to produce and provide radiopharmaceuticals and radioisotopes across the Asia Pacific region. An increase in nuclear imaging methods in Asia Pacific is also contributing to the market adoption.
Radiotheranostics Market- Competitive Landscape:
Several strategic measures are being implemented by prominent players such as Telix Pharmaceuticals Limited., Novartis AG, IsoTherapeutics Group, LLC, Bayer AG, and Progenics Pharmaceuticals, Inc.( Lantheus), among others in the radiotheranostics sector to fortify their position and maintain their competitiveness. To improve radiotheranostics technologies, they are heavily funding research and development (R&D) projects that concentrate on creating novel radiopharmaceuticals, enhancing imaging agents, and expanding therapeutic potential. To gain access to resources, exchange knowledge, and capitalize on expertise, they are forming alliances with academic institutions, research centers, and other industry participants. Furthermore, partnerships among industry leaders enable businesses to improve the caliber of their products, broaden their customer base, and expedite the creation of new products.
Recent Developments:
March 2023: Pharma 15 Corporation, a US-based business focused on creating cutting-edge therapeutic radiopharmaceuticals for prostate cancer, has been acquired by Radiopharm Theranostics. Through this calculated move, Radiopharm Theranostics was able to expand its portfolio and solidify its position in the radiotheranostics industry by gaining access to cutting-edge technology and knowledge in the treatment of prostate cancer.
June 2023: Thor Medical, a young manufacturer of alpha-emitters for radiopharmaceuticals intended to cure cancer, was acquired by Nordic Nanovector. By incorporating Thor Medical's knowledge and alpha-emitter technology, this calculated move strengthened Nordic Nanovector's capabilities, diversifying its product line and solidifying its position in the cancer market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RADIOTHERANOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Telix Pharmaceuticals Limited.
Novartis AG
IsoTherapeutics Group, LLC
Bayer AG
Progenics Pharmaceuticals, Inc.( Lantheus)
ITM Radiopharma
Q BioMed Inc.
Life Molecular Imaging
RadioMedix
Nordic Nanovector ASA
Others
GLOBAL RADIOTHERANOSTICS MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032
- Iodine-131
- lodine-123
- Gallium-68
- Lutetium-177
- 18F with Y-90
- Other radioisotopes
GLOBAL RADIOTHERANOSTICS MARKET, BY APPROACH- MARKET ANALYSIS, 2019 - 2032
- Targeted therapeutic
- Targeted diagnostic
GLOBAL RADIOTHERANOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Oncology
- Thyroid cancer
- Neuroendocrine tumors
- Hepatocellular carcinoma
- Prostate cancer
- Other oncology applications
- Non-oncology
- Neurological disorders
- Arthritis
- Other non-oncology applications
GLOBAL RADIOTHERANOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Radiotheranostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Radiotheranostics Market Snippet by Radioisotope
- 2.1.2. Radiotheranostics Market Snippet by Approach
- 2.1.3. Radiotheranostics Market Snippet by Application
- 2.1.4. Radiotheranostics Market Snippet by Country
- 2.1.5. Radiotheranostics Market Snippet by Region
- 2.2. Competitive Insights
3. Radiotheranostics Key Market Trends
- 3.1. Radiotheranostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Radiotheranostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Radiotheranostics Market Opportunities
- 3.4. Radiotheranostics Market Future Trends
4. Radiotheranostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Radiotheranostics Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Radiotheranostics Market Landscape
- 6.1. Radiotheranostics Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Radiotheranostics Market - By Radioisotope
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
- 7.1.2. Iodine-131
- 7.1.3. lodine-123
- 7.1.4. Gallium-68
- 7.1.5. Lutetium-177
- 7.1.6. 18F with Y-90
- 7.1.7. Other radioisotopes
8. Radiotheranostics Market - By Approach
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Approach, 2023 & 2032 (%)
- 8.1.2. Targeted therapeutic
- 8.1.3. Targeted diagnostic
9. Radiotheranostics Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Oncology
- 9.1.2.1. Thyroid cancer
- 9.1.2.2. Neuroendocrine tumors
- 9.1.2.3. Hepatocellular carcinoma
- 9.1.2.4. Prostate cancer
- 9.1.2.5. Other oncology applications
- 9.1.3. Non-oncology
- 9.1.3.1. Neurological disorders
- 9.1.3.2. Arthritis
- 9.1.3.3. Other non-oncology applications
10. Radiotheranostics Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Radiotheranostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Radiotheranostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Radiotheranostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Radiotheranostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Radiotheranostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Approach, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Radiotheranostics Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Telix Pharmaceuticals Limited.
- 11.2.2. Novartis AG
- 11.2.3. IsoTherapeutics Group, LLC
- 11.2.4. Bayer AG
- 11.2.5. Progenics Pharmaceuticals, Inc.( Lantheus)
- 11.2.6. ITM Radiopharma
- 11.2.7. Q BioMed Inc.
- 11.2.8. Life Molecular Imaging
- 11.2.9. RadioMedix
- 11.2.10. Nordic Nanovector ASA
- 11.2.11. Others
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Radiotheranostics Market: Radioisotope Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Radioisotope
- TABLE Global Radiotheranostics Market, by Radioisotope 2019-2032 (USD Million)
- TABLE Radiotheranostics Market: Approach Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Approach
- TABLE Global Radiotheranostics Market, by Approach 2019-2032 (USD Million)
- TABLE Radiotheranostics Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global Radiotheranostics Market, by Application 2019-2032 (USD Million)
- TABLE Radiotheranostics Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Radiotheranostics Market, by Region 2019-2032 (USD Million)
- TABLE North America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
- TABLE North America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
- TABLE North America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
- TABLE North America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
- TABLE Europe Radiotheranostics Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
- TABLE Europe Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
- TABLE Europe Radiotheranostics Market, by Application, 2019-2032 (USD Million)
- TABLE Asia Pacific Radiotheranostics Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
- TABLE Asia Pacific Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
- TABLE Asia Pacific Radiotheranostics Market, by Application, 2019-2032 (USD Million)
- TABLE Latin America Radiotheranostics Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
- TABLE Latin America Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
- TABLE Latin America Radiotheranostics Market, by Application, 2019-2032 (USD Million)
- TABLE Middle East and Africa Radiotheranostics Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Radiotheranostics Market, by Radioisotope, 2019-2032 (USD Million)
- TABLE Middle East and Africa Radiotheranostics Market, by Approach, 2019-2032 (USD Million)
- TABLE Middle East and Africa Radiotheranostics Market, by Application, 2019-2032 (USD Million)
